Covidien Valleylab FT10, FT Series Energy Platform, REF: VLFT10GEN, DLVLFT10GEN, VLFT10GENZD

FDA Device Recall #Z-0631-2024 — Class II — November 16, 2023

Recall Summary

Recall Number Z-0631-2024
Classification Class II — Moderate risk
Date Initiated November 16, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Covidien
Location Lafayette, CO
Product Type Devices
Quantity 47,901 units

Product Description

Covidien Valleylab FT10, FT Series Energy Platform, REF: VLFT10GEN, DLVLFT10GEN, VLFT10GENZD

Reason for Recall

Due to software issue, New systems may exhibit an error which may prohibit use of new systems resulting in system being inoperable

Distribution Pattern

Worldwide distribution - US: Nationwide and surrounding territories.

Lot / Code Information

Ref-UDI: VLFT10GEN- 10884521516328, DLVLFT10GEN - 10884521787056 , VLFT10GENZD - 10884521640474/Software: v4.0.1, v4.0.2 and v4.0.3

Other Recalls from Covidien

Recall # Classification Product Date
Z-2151-2025 Class II Covidien Nellcor Bedside SpO2 Patient Monitorin... Jun 23, 2025
Z-1915-2025 Class I Newport HT70 Ventilator, REF: HT70M-JP-NA, HT70... May 21, 2025
Z-1390-2025 Class I Shiley Adult Flexible Tracheostomy Tube with Ta... Feb 26, 2025
Z-2717-2024 Class II Covideien McGRATH MAC Video Laryngoscope, REF: ... Jul 9, 2024
Z-2636-2024 Class I McGrath Mac Video Laryngoscope, REF: 300-000-00... Jul 9, 2024

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.